Marshall Wace
EHC icon

Marshall Wace’s Encompass Health EHC Stock Holding History

Marshall Wace’s Portfolio EHC Stock Details EHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$225K Sell
2,227
-295,408
-99% -$30.6M ﹤0.01% 2801
2026
Q1 		$28.8M Buy
297,635
+282,706
+1,894% +$29M 0.03% 564
2025
Q4 		$1.58M Sell
14,929
-71,291
-83% -$8.26M ﹤0.01% 1687
2025
Q3 		$11M Sell
86,220
-196,902
-70% -$23.4M 0.01% 887
2025
Q2 		$34.7M Buy
+283,122
New +$32.3M 0.04% 399
2023
Q3 		– Sell
-10,549
Closed -$714K – 2307
2023
Q2 		$714K Sell
10,549
-196,004
-95% -$12.3M ﹤0.01% 1854
2023
Q1 		$11.2M Buy
+206,553
New +$12M 0.02% 674
2022
Q4 		– Sell
-4,800
Closed -$216K – 3049
2022
Q3 		$216K Sell
4,800
-55,526
-92% -$2.78M ﹤0.01% 3063
2022
Q2 		$2.69M Sell
60,326
-34,811
-37% -$1.79M 0.01% 1791
2022
Q1 		$5.38M Buy
+95,137
New +$4.97M 0.01% 1306
2020
Q1 		– Sell
-141,322
Closed -$7.79M – 1728
2019
Q4 		$7.79M Sell
141,322
-292,442
-67% -$15.9M 0.05% 372
2019
Q3 		$21.8M Sell
433,764
-138,326
-24% -$6.95M 0.17% 137
2019
Q2 		$28.8M Buy
572,090
+430,939
+305% +$20.9M 0.24% 87
2019
Q1 		$6.56M Buy
141,151
+89,765
+175% +$4.55M 0.06% 387
2018
Q4 		$2.52M Buy
+51,386
New +$2.92M 0.03% 668
2016
Q1 		– Sell
-148,546
Closed -$4.11M – 1062
2015
Q4 		$4.11M Buy
148,546
+104,511
+237% +$2.97M 0.04% 417
2015
Q3 		$1.34M Sell
44,035
-4,185
-9% -$146K 0.02% 567
2015
Q2 		$1.77M Buy
+48,220
New +$1.72M 0.02% 499

Other funds holding EHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Marshall Wace's EHC Position: Q2 2026 in Review

Marshall Wace reduced its Encompass Health (EHC) stake by 99% in Q2 2026, selling an estimated $30.6M and leaving 2,227 shares worth $225K. The position accounts for ﹤0.01% of the portfolio, ranked #2801.

Marshall Wace first reported a position in EHC in Q2 2015 and has held it in 18 quarters since. The position peaked at $34.7M in Q2 2025. 598 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Marshall Wace held 2,227 shares of Encompass Health worth $225K as of Q2 2026.
  • Marshall Wace sold 295,408 Encompass Health shares in Q2 2026, an estimated $30.6M.
  • Encompass Health made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #2801 holding.
  • Marshall Wace first reported a position in Encompass Health in Q2 2015 and has held it in 18 quarters since.
  • Marshall Wace's Encompass Health position peaked at $34.7M in Q2 2025.
  • 598 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.